Welcome to our dedicated page for ANGPRA news (Ticker: ANGPRA), a resource for investors and traders seeking the latest updates and insights on ANGPRA stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ANGPRA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ANGPRA's position in the market.
American National Group has announced the full redemption of its 16,000 outstanding shares of 5.95% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series A, and corresponding 16 million depositary shares on February 24, 2025. Each depositary share, representing a 1/1,000th interest in Series A Preferred Stock, will be redeemed at $25.00 plus any declared but unpaid dividends.
The redemption will be processed through The Depository Trust Company, with Computershare Inc. acting as the redemption agent. Following the redemption, the company plans to delist the Depositary Shares from the NYSE and deregister them with the SEC. The deregistration is expected to become effective 90 days after filing Form 15.
